These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Use of mitochondrial inhibitors to differentiate kinetic properties of the ATP-dependent Ca2+ uptake system in synaptic membranes.
    Author: Ross DH, Garrett KM, Cardenas HL.
    Journal: Neurochem Res; 1985 Feb; 10(2):269-82. PubMed ID: 3990895.
    Abstract:
    Synaptosomal membranes accumulate 3-6 times more Ca2+ in the presence of ATP (50-1000 microM) than basal Ca2+ accumulation (-ATP). The location of this Ca2+ accumulation appears to reside on the cytosolic face of the synaptosome since lysed synaptosomes accumulate 4-times more Ca2+ than intact synaptosomes. The inclusion of mitochondrial inhibitors, oligomycin (0.7 micrograms/ml), sodium azide (100 microM) and dinitrophenol (100 microM) differentiate mitochondrial from nonmitochondrial Ca2+ accumulation under conditions that are [Ca2+]- and ATP-dependent. In the presence of low concentrations of ATP (less than 150 microM) and Ca2+ free (2.5 or 6.8 microM), Ca2+ accumulation occurs as one process in both lysed synaptosomal membranes and purified synaptic plasma membranes in the presence and/or absence of MI. When ATP levels are increased (greater than 200 microM), Ca2+ accumulation process remains independent of the presence of mitochondrial inhibitors when Ca2+ free = 2.5 microM. When Ca2+ free is increased to 6.8 microM, mitochondrial inhibitors differentiate mitochondrial from nonmitochondrial accumulation. These studies suggest that optimal conditions for the measurement of Ca2+ accumulating mechanisms in synaptosomal membranes depend on both [Ca2+] and ATP. Use of these assay conditions provide evidence that ATP-dependent Ca2+ uptake may be a viable mechanism for the regulation of synaptosomal Ca2+ levels.
    [Abstract] [Full Text] [Related] [New Search]